Serum ustekinumab and corresponding anti-ustekinumab antibody: Analysis of over 2000 patient results using lab developed chemiluminescent immunoassays (ECLIA)

Pro-inflammatory small LDL-like particles in patients with severe liver disease

Characterization of LP-Z abnormal lipoprotein particles and quantification in subjects with liver disease

A novel lipoprotein-based Z-index robustly predicts 90-day mortality in severe alcoholic hepatitis

JAK2 exons 12, 13, 14 and 15 mutation analysis

MLH1 promoter methylation analysis